UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 147

Sortiert nach

Treatment-Related Risk Factors for Transformation to Acute Myeloid Leukemia and Myelodysplastic Syndromes in Myeloproliferative Neoplasms

Journal of clinical oncology, 2011-06, Vol.29 (17), p.2410-2415

2011

Link zum Volltext

Verfügbarkeit prüfen

Addition of intravenous iron to epoetin beta increases hemoglobin response and decreases epoetin dose requirement in anemic patients with lymphoproliferative malignancies: a randomized multicenter study

Leukemia, 2007-04, Vol.21 (4), p.627-632

2007

Link zum Volltext

Verfügbarkeit prüfen

The outcome of allo-HSCT for 92 patients with myelofibrosis in the Nordic countries

Bone marrow transplantation (Basingstoke), 2012-03, Vol.47 (3), p.380-386

2012

Link zum Volltext

Verfügbarkeit prüfen

THU0061 Anemia in patients with rheumatoid arthritis: A cross-sectional study

Annals of the rheumatic diseases, 2013-06, Vol.71 (Suppl 3), p.173-173

2013

Link zum Volltext

Verfügbarkeit prüfen

A unified definition of clinical resistance intolerance to hydroxyurea in essential thrombocythemia: results of a consensus process by an international working group

Leukemia, 2007-02, Vol.21 (2), p.277-280

2007

Link zum Volltext

Verfügbarkeit prüfen

Which patients with myelofibrosis should receive ruxolitinib therapy? ELN-SIE evidence-based recommendations

Leukemia, 2017-04, Vol.31 (4), p.882-888

2017

Link zum Volltext

Verfügbarkeit prüfen

Too-low iron doses and too many dropouts in negative iron trial?

Journal of clinical oncology, 2011-06, Vol.29 (17), p.e525-e526

2011

Link zum Volltext

Verfügbarkeit prüfen

Philadelphia-Negative Classical Myeloproliferative Neoplasms: Critical Concepts and Management Recommendations From European LeukemiaNet

Journal of clinical oncology, 2011-02, Vol.29 (6), p.761-770

2011

Link zum Volltext

Verfügbarkeit prüfen

Symptomatic burden in myelofibrosis (MF): Prospective international assessment in 128 MF patients

JOURNAL OF CLINICAL ONCOLOGY, 2011-05, Vol.29 (15_suppl), p.6610-6610

2011

Link zum Volltext

Verfügbarkeit prüfen

The Myeloproliferative Neoplasm Symptom Assessment Form (MPN-SAF): International Prospective Validation and Reliability Trial in 402 patients

Blood, 2011-07, Vol.118 (2), p.401-408

2011

Link zum Volltext

Verfügbarkeit prüfen

High incidence of iron depletion and restless leg syndrome (RLS) in regular blood donors: intravenous iron sucrose substitution more effective than oral iron

Vox sanguinis, 2010-11, Vol.99 (4), p.354-361

2010

Link zum Volltext

Verfügbarkeit prüfen

Five-year follow-up of survival and relapse in patients who received cryotherapy during high-dose chemotherapy for stem cell transplantation shows no safety concerns

European journal of cancer care, 2012-11, Vol.21 (6), p.822-828

2012

Link zum Volltext

Verfügbarkeit prüfen

Addition of intravenous iron to epoetin beta increases hemoglobin response and decreases epoetin dose requirement in anemic patients with lymphoproliferative malignancies: a randomized multicenter study

Leukemia, 2008-02, Vol.22 (2), p.462-462

2008

Link zum Volltext

Verfügbarkeit prüfen

The European Cancer Anaemia Survey (ECAS): A large, multinational, prospective survey defining the prevalence, incidence, and treatment of anaemia in cancer patients

European journal of cancer (1990), 2004-10, Vol.40 (15), p.2293-2306

2004

Link zum Volltext

Verfügbarkeit prüfen

Myeloproliferative Neoplasm (MPN) Symptom Assessment Form Total Symptom Score: Prospective International Assessment of an Abbreviated Symptom Burden Scoring System Among Patients With MPNs

Journal of clinical oncology, 2012-11, Vol.30 (33), p.4098-4103

2012

Link zum Volltext

Verfügbarkeit prüfen

Caphosol® mouthwash gives no additional protection against oral mucositis compared to cryotherapy alone in stem cell transplantation. A pilot study

European journal of oncology nursing : the official journal of European Oncology Nursing Society, 2015-02, Vol.19 (1), p.50-53

2015

Link zum Volltext

Verfügbarkeit prüfen

Symptomatic Profiles of Patients With Polycythemia Vera: Implications of Inadequately Controlled Disease

Journal of clinical oncology, 2016-01, Vol.34 (2), p.151-159

2016

Link zum Volltext

Verfügbarkeit prüfen

Anagrelide Treatment in Myeloproliferative Disorders

Seminars in thrombosis and hemostasis, 2006-04, Vol.32 (3), p.260-266

Birgegard, Gunnar

2006

Link zum Volltext

Verfügbarkeit prüfen

Does anything work for anaemia in myelofibrosis?

Best practice & research. Clinical haematology, 2014-06, Vol.27 (2), p.175-185

Birgegard, Gunnar

2014

Link zum Volltext

Verfügbarkeit prüfen

Oral cryotherapy reduces mucositis and improves nutrition - a randomised controlled trial

Journal of clinical nursing, 2010-08, Vol.19 (15-16), p.2146-2151

2010

Link zum Volltext

Verfügbarkeit prüfen

A unified definition of clinical resistance intolerance to hydroxyurea in essential thrombocythemia: results of a consensus process by an international working group

Leukemia, 2007-05, Vol.21 (5), p.1136-1136

2007

Link zum Volltext

Verfügbarkeit prüfen

Which patients with myelofibrosis should receive ruxolitinib therapyquest; ELN-SIE evidence-based recommendations.(Original Article)

Leukemia, 2017-04, Vol.31 (4), p.882

2017

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 147

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(141)
Mit Volltextzugriff
(104)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Humans
(104)
Life Sciences & Biomedicine
(94)
Science & Technology
(94)
Male
(65)
Female
(63)
Adult
(54)
Middle Aged
(49)
Hematology
(46)
Medicin Och Hälsovetenskap
(46)
Medicine
(41)
Medicin
(40)
Aged
(35)
Biological And Medical Sciences
(34)
Medical Sciences
(32)
Oncology
(31)
Ferritins - Blood
(20)
Erythropoietin
(14)
Erythropoietin - Blood
(14)
Hematologic And Hematopoietic Diseases
(14)
Hemoglobins - Analysis
(14)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Treatment-Related Risk Factors for Transformation to Acute Myeloid Leukemia and Myelodysplastic Syndromes in Myeloproliferative Neoplasms

Addition of intravenous iron to epoetin beta increases hemoglobin response and decreases epoetin dose requirement in anemic patients with lymphoproliferative malignancies: a randomized multicenter study

The outcome of allo-HSCT for 92 patients with myelofibrosis in the Nordic countries

Clinical end points for drug treatment trials in BCR-ABL1-negative classic myeloproliferative neoplasms: consensus statements from European LeukemiaNET (ELN) and Internation Working Group-Myeloproliferative Neoplasms Research and Treatment (IWG-MRT)

THU0061 Anemia in patients with rheumatoid arthritis: A cross-sectional study

A unified definition of clinical resistance intolerance to hydroxyurea in essential thrombocythemia: results of a consensus process by an international working group

Which patients with myelofibrosis should receive ruxolitinib therapy? ELN-SIE evidence-based recommendations

Too-low iron doses and too many dropouts in negative iron trial?

Philadelphia chromosome-negative classical myeloproliferative neoplasms: revised management recommendations from European LeukemiaNet

Philadelphia-Negative Classical Myeloproliferative Neoplasms: Critical Concepts and Management Recommendations From European LeukemiaNet

Symptomatic burden in myelofibrosis (MF): Prospective international assessment in 128 MF patients

The Myeloproliferative Neoplasm Symptom Assessment Form (MPN-SAF): International Prospective Validation and Reliability Trial in 402 patients

High incidence of iron depletion and restless leg syndrome (RLS) in regular blood donors: intravenous iron sucrose substitution more effective than oral iron

Five-year follow-up of survival and relapse in patients who received cryotherapy during high-dose chemotherapy for stem cell transplantation shows no safety concerns

Addition of intravenous iron to epoetin beta increases hemoglobin response and decreases epoetin dose requirement in anemic patients with lymphoproliferative malignancies: a randomized multicenter study

Distinct clustering of symptomatic burden among myeloproliferative neoplasm patients: retrospective assessment in 1470 patients

The European Cancer Anaemia Survey (ECAS): A large, multinational, prospective survey defining the prevalence, incidence, and treatment of anaemia in cancer patients

Myeloproliferative Neoplasm (MPN) Symptom Assessment Form Total Symptom Score: Prospective International Assessment of an Abbreviated Symptom Burden Scoring System Among Patients With MPNs

Caphosol® mouthwash gives no additional protection against oral mucositis compared to cryotherapy alone in stem cell transplantation. A pilot study

Symptomatic Profiles of Patients With Polycythemia Vera: Implications of Inadequately Controlled Disease

Anagrelide Treatment in Myeloproliferative Disorders

Does anything work for anaemia in myelofibrosis?

Oral cryotherapy reduces mucositis and improves nutrition - a randomised controlled trial

A unified definition of clinical resistance intolerance to hydroxyurea in essential thrombocythemia: results of a consensus process by an international working group

Which patients with myelofibrosis should receive ruxolitinib therapyquest; ELN-SIE evidence-based recommendations.(Original Article)

Suchergebnisse filtern